The tumor suppressor PTEN serves as a negative regulator of the PI3K/AKT signaling pathway, and inhibition of PTEN activity can activate the AKT signal transduction pathway (Bu et al. 2021; Driessen et al. 2016; Wishart and Dixon 2002; Yue et al. 2014). This evidence concerns the gene PTEN and neoplasm.